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T follicular helper (Tfh) cells represent a recently
defined CD4+ T cell subset characterized by the
expression of the chemokine receptor CXCR5 and
an enhanced ability to support B cells to mount anti-
body responses. Here, we demonstrate that lymph-
node-resident CXCR5+ Tfh cells and gut-homing
integrin a4b7-expressing T helper cells are generated
as separate subsets in the gut-draining mesenteric
lymph nodes. Type I interferon signaling in dendritic
cells and in nonhematopoietic cells selectively stim-
ulates Tfh cell development in response to antigen in
conjunction with Toll-like receptor (TLR)3 or TLR4
agonists. Consistent with this, the ability of dendritic
cells to produce the cytokine IL-6, required for in vivo
Tfh differentiation, and antibody affinity maturation
are both reduced in absence of type I interferon
signaling. Thus, our results identify type I interferon
as a natural adjuvant that selectively supports the
generation of lymph node resident Tfh cells.
INTRODUCTION
Antibody (Ab) affinity maturation and generation of B cell
memory occur within the specialized microenvironment of
germinal centers (GC) that develop within B cell follicles of
secondary lymphoid organs (Berek et al., 1991; Blink et al.,
2005; Jacob et al., 1991; Takahashi et al., 1998). Whereas these
processes are mandatory for production of long-lived IgG
responses, conferring protection following natural infection, or
in settings of vaccination, they may also lead to the generation
of autoantibodies and autoimmune disease (Shlomchik et al.,
1987). GC B cell differentiation is dependent on help provided
by CD4+ T helper (Th) cells (MacLennan et al., 1997). Accumu-
lating evidence indicates that expression of the chemokine
receptor CXCR5, whose ligand CXCL13 is strongly produced
within B cell follicles (Gunn et al., 1998), distinguishes a subset
of T follicular helper (Tfh) cells with an enhanced ability toIprovide B cell help (Ansel et al., 1999; Breitfeld et al., 2000;
Campbell et al., 2001; Schaerli et al., 2000) and that appear to
be developmentally distinct from Th1, Th2, and Th17 cells (Nur-
ieva et al., 2008). In addition to CXCR5, Tfh cells have high IL-21
and Bcl-6 mRNA expression (Chtanova et al., 2004), and IL-21
was recently shown to regulate their generation, possibly in an
autocrine way (Nurieva et al., 2008; Vogelzang et al., 2008).
Expression of IL-21 is in turn induced by IL-6 that is required
for Tfh differentiation in vivo (Nurieva et al., 2008; Suto et al.,
2008).
CXCR5+ Tfh cells develop preferentially in the draining lymph
node (LN) from precursors that express high-affinity T cell
receptors (TCRs), and resting memory Tfh cells persist in the
draining, but not in nondraining, LN after contraction of the
adaptive immune response (Fazilleau et al., 2007). Activation
of CD4+ T cells in skin-associated LNs leads to the concurrent
generation of peripheral tissue-tropic CXCR5 effector Th cells,
expressing high amounts of the skin-homing molecule P-selec-
tin ligand (P-lig) and P-ligCD62LCXCR5+ Tfh cells, and these
subsets appear to be functionally specialized in supporting
cutaneous inflammation and B cell Ab production, respectively
(Campbell et al., 2001). How this spatial dichotomy is estab-
lished is currently not entirely clear. Whether distinct subsets
of Tfh cells and peripheral effector CD4+ T cells develop in
lymphoid tissues other than cutaneous LNs also remains to be
determined.
Type I interferons (IFN I) represent a family of cytokines with
antiviral and immunomodulatory activities (Theofilopoulos
et al., 2005). IFN-b and multiple IFN-a proteins are produced at
high amounts in response to viral and bacterial infections and
signal through a common IFN I receptor (IFNAR) (Theofilopoulos
et al., 2005). IFN I enhances T cell-dependent Ab responses
in vivo and seems to mediate this effect at least partially through
signaling in dendritic cells (DCs) (Le Bon et al., 2001). Consistent
with this, IFN-a and -b underlie the ability of the TLR3 and TLR4
agonists pI:C and LPS, respectively, to induce upregulation of
costimulatory molecules on antigen-presenting cells (APC)
(Hoebe et al., 2003). Collectively, these observations led us to
hypothesize that IFN I enhances T cell-dependent Ab responses
by acting as a natural adjuvant for the generation of CXCR5+ Tfh
cells.mmunity 31, 491–501, September 18, 2009 ª2009 Elsevier Inc. 491
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Generation of Separate CXCR5+ Tfh Cell and a4b7
+ Gut-
Homing CD4+ T Cell Subsets in the Mesenteric LNs
T cells homing to the gut express the integrin a4b7, whose ligand
MadCAM-1 is present on intestinal postcapillary endothelial cells
(Berlin et al., 1993; Lefrancois et al., 1999). Expression of a4b7 is
selectively induced on T cells activated in intestinal inductive
sites, including the gut-draining mesenteric LN (MLN) (Campbell
and Butcher, 2002). To determine if the MLN supports generation
of CXCR5+ Tfh cells that are distinct from a4b7
+ gut-homing
T cells, we transferred CFSE-labeled OVA-specific TCR trans-
genic CD4+ T (OT-II) cells to wild-type (WT) recipients and deter-
mined the phenotype of donor cells 3 days after intraperitoneal
(i.p.) immunization with OVA. In the MLN, but not in the spleen,
a substantial proportion of divided OT-II cells expressed a4b7
regardless if adjuvant was coinjected or not (Figure 1A). Whereas
expression of CXCR5 on T cells requires adjuvant (Ansel et al.,
1999), the large majority of MLN OT-II cells that acquired
CXCR5 in the presence of LPS, pI:C, or an agonistic CD40 mAb
were a4b7
 (Figures 1A–1C). Consistent with prior characteriza-
tions of Tfh cells (Chtanova et al., 2004; Haynes et al., 2007),
the MLN CXCR5+a4b7
 OT-II cells expressed higher amounts
of IL-21 and Bcl-6 mRNA and contained less CCR7 mRNA, as
Figure 1. Generation of Separate Subsets
of CXCR5+ Tfh Cells and a4b7
+ Th Cells in
the MLN
CFSE-labeled CD45.2+ OT-II cells were trans-
ferred into C57Bl/6-CD45.1 mice and analyzed
3 days after i.p. immunization.
(A and B) Representative flow cytometry analyses
of OT-II cells in indicated organs after immuniza-
tion with OVA in presence or absence of pI:C (A)
or together with LPS or anti-CD40 (B). Numbers
indicate percentages of cells within the quadrants.
Cell division dependent dilution of CFSE and
gating of CD45.2+ donor cells among PICD4+
B220 cells are shown in top panel of (A).
(C) Percentages of MLN CXCR5+ and CXCR5
OT-II cells coexpressing a4b7. Pooled results
(mean ± SD) from six experiments with pI:C, nine
with LPS, and two with anti-CD40 (3 to 4 mice in
each experiment).
(D and E) Expression of IL-21, CCR7, and Bcl-6
mRNA in MLN and spleen OT-II cells with indi-
cated phenotypes at day 3 (n = 4–10) (D) and
day 5 (n = 10) (E) postimmunization (mean ± SD).
Expression is normalized to b-actin. ***p < 0.001;
**p < 0.01; *p < 0.05.
compared to their a4b7
+CXCR5 counter-
parts (Figure 1D). This differential expres-
sion in IL-21 and Bcl-6 mRNA was
also evident 5 days after immunization
(Figure 1E), and similar results were
obtained with CXCR5+ and CXCR5
OT-II cells sorted from the spleen (Figures
1D and 1E). These results collectively
show that Tfh cells are generated in the
MLN and spleen after i.p. immunization
with a protein in adjuvant and that CXCR5+a4b7
 Tfh cells
and a4b7
+ gut-homing Th cells develop as two distinct subsets
in the MLN.
The LargeMajority of a4b7
+ ThCells, but Not CXCR5+ Tfh
Cells, Generated in MLN Rapidly Exit the Lymph Node
Although the majority of OT-II cells homing to the gut expressed
a4b7, few CXCR5
+ OT-II cells were detected in this site and their
proportion was also lower in the liver as compared to MLN and
spleen (Figures 2A and 2B). It hence appears as CXCR5+ and
a4b7
+ OT-II cells differ in their ability to exit LNs and to localize
to peripheral tissues. To determine their LN egress efficiencies,
we treated recipients with the sphingosine 1-phosphate
receptor-1 (S1P1) agonist FTY720 that shuts down lymphocyte
egress from lymphoid tissues (Matloubian et al., 2004). Three
days after immunization, the number of OT-II cells was 3 times
higher in the MLN of FTY720 treated mice as compared to
controls, and consistent with an FTY720-mediated LN reten-
tion, they were essentially absent from peripheral blood of
treated mice (Figure 2C). This was accompanied by a large
proportional increase in a4b7
+CXCR5 OT-II cells in the MLN
of the FTY720-treated mice (Figure 2D), corresponding to an
almost 10-fold increased number of these cells, but only
1.7-fold higher number of the CXCR5+a4b7 OT-II cells492 Immunity 31, 491–501, September 18, 2009 ª2009 Elsevier Inc.
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IFN I-Dependent Generation of Tfh CellsFigure 2. CXCR5+ Tfh Cells Are Selectively
Retained in the MLN
(A) Expression of CXCR5 versus a4b7 on OT-II cells
in MLN and small intestinal lamina propria (SI LP)
3–7 days after immunization with OVA and pI:C.
Results are representative of three mice for each
time point, and similar results were obtained in
a second experiment with OVA plus LPS.
(B) Percentages of CXCR5+ OT-II cells in indicated
organs 3 days after immunization with OVA and
adjuvant (mean ± SD, n = 12). Pooled data from
four separate experiments (two with LPS and
two with pI:C).
(C–F) Recipients received FTY720 or saline i.p.
18–24 hr after immunization, and the number and
phenotype of OT-II cells in indicated organs were
determined 3 days postimmunization. Pooled
results (mean ± SD, n = 9) from three separate
experiments (two with LPS and one with pI:C)
are shown in (C) and (E). (C) Total number of
OT-II cells in indicated tissues. (D) Representative
flow cytometry results for expression of CXCR5
versus a4b7. Numbers indicate percentages
of cells within quadrants. (E) Number of OT-II
cells with indicated phenotype. (F) Percentages
(mean ± SD) of OT-II cells with indicated pheno-
type retained within the MLN. Results were
obtained by calculating the ratio between saline-
and FTY720-treated mice for each subset and
are based on the mean of ratios obtained in
the separate experiments in (E). ***p < 0.001;
**p < 0.01; *p < 0.05.(Figure 2E). The small fraction of cells that coexpressed a4b7
and CXCR5 also displayed a 10-fold higher number following
FTY720 treatment (Figure 2E), indicating that all a4b7
+ Th cells
exit the LN with similar high efficiency. In keeping with the effi-
cient egress of these cells from the MLN, a large number of
a4b7
+ OT-II cells was present in spleen of saline-treated, but
not FTY720-treated, mice (Figures 2D and 2E). While we could
only detect a tendency of reduced S1P1 mRNA in CXCR5
+a4b7

compared with a4b7
+CXCR5 OT-II cells, expression of CD69
was confined to the former subset at this time point (Figure S1
available online). Maintained CD69 expression on Tfh cells
may hence partially underlie their LN sequestration, as previ-
ously suggested (Fazilleau et al., 2007; Shiow et al., 2006).
Finally, there was no difference in the number of OT-II cells
lacking both CXCR5 and a4b7 between FTY720- and saline-
treated mice (Figure S2A). These double-negative cells failed
to efficiently downregulate CD62L (Figure S2B) and seem to
represent a second subset of LN-resident Th cells that, by virtue
of their CXCR5 phenotype, are excluded from the follicles. We
have not characterized this subset any further. These results
collectively demonstrate that the majority of donor cells
expanded in the MLN, and more than 90% of the numerous
a4b7
+ OT-II cells generated at this site, rapidly exit the LN. In
marked contrast, most CXCR5+a4b7
 OT-II cells are retained
within the LN (Figure 2F).ICXCR5+ Tfh Cells Display Lymphoid-Tissue-Specific
Cytokine Production and Are Preferentially Generated
under Strong Immunogenic Conditions
When restimulated in vitro, MLN a4b7
+CXCR5 OT-II cells from
mice immunized with OVA plus LPS produced IL-4, IL-10, and
IL-17, but not IFN-g (Figure 3A). In the spleen, the CXCR5
OT-II cells produced negligible amounts of IL-4 and IL-17,
moderate amounts of IL-10, and relatively large quantities of
IFN-g (Figure 3A). Although this indicates that the MLN and
spleen imprint different Th cell cytokine responses, MLN
CXCR5+a4b7
 and spleen CXCR5+ OT-II cells produced rela-
tively low amounts of IL-10, IL-17, and IFN-g. In the MLN, but
not in the spleen, the CXCR5+ Tfh cell subset, however, secreted
substantial amounts of IL-4 (Figure 3A), suggesting that the
nature of Tfh responses also differs between these lymphoid
tissues.
Both in the absence and presence of FTY720, CXCR5+ OT-II
cells had downregulated CD62L more efficiently than the
CXCR5 fraction (Figure 3B), and whereas only the most divided
cells expressed CXCR5, a4b7 was detectable also on less-cycled
cells (Figure 3C). These observations collectively suggest that
CXCR5+ Tfh cells represent robustly activated effector cells (Lan-
zavecchia and Sallusto, 2000). To determine if strong immuno-
genic conditions enhance their generation, we immunized mice
with OVA plus pI:C, an agonistic CD40 mAb, or both together.mmunity 31, 491–501, September 18, 2009 ª2009 Elsevier Inc. 493
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IFN I-Dependent Generation of Tfh CellsFigure 3. Tfh Cells Display Lymphoid-Tissue-Specific Cytokine
Production and Are Preferentially Generated under Strong Immuno-
genic Conditions
(A) OT-II cell recipients received FTY720 24 hr after immunization with OVA and
LPS, and donor cells with a Tfh cell phenotype (CXCR5+a4b7
 in MLN; CXCR5+
in spleen) or a non-Tfh cell phenotype (CXCR5a4b7
+ in MLN; CXCR5 in
spleen) were sorted from six pooled mice 3 days after immunization. Cells
were restimulated at 106 cells/ml with anti-CD3 and anti-CD28 for 24 hr, and
supernatants were analyzed for indicated cytokines by ELISA. One represen-
tative experiment of two performed is shown.
(B) Recipients of CFSE-labeled OT-II cells received saline or FTY720 24 hr after
i.p. immunization with OVA and LPS, and percentages of CXCR5+ or CXCR5
MLN OT-II cells expressing CD62L were determined 3 days after immunization
by flow cytometry. Pooled results (mean ± SD; n = 6) from two separate exper-
iments.
(C) Representative flow cytometry results of CXCR5 and a4b7 expression by
MLN OT-II in relation to CFSE dilution.
(D–F) Recipients were immunized with OVA alone or together with pI:C, anti-
CD40, or both. OT-II cells in MLN were analyzed 3 days later by flow cytometry.
(D) Percentages of total OT-II cells as a function of cell division. (E) Percent-
ages of OT-II cells expressing CD62L. (F) Percentages of OT-II cells expressing
CXCR5 or a4b7. Results from one representative experiment (mean ± SD; n = 3)
of two performed are shown. ***p < 0.001; **p < 0.01.494 Immunity 31, 491–501, September 18, 2009 ª2009 Elsevier Inc.Although the combination did not further enhance the adjuvant-
dependent increase in OT-II cell proliferation (Figure 3D),
it more efficiently downregulated CD62L than when pI:C or
anti-CD40 were injected separately (Figure 3E). This was accom-
panied by a 2-fold greater fraction of CXCR5+ MLN OT-II cells
(Figure 3F). The proportional number of a4b7
+ donor cells did,
however, not differ between the different groups. The ability of
pI:C and anti-CD40 to additively enhance CXCR5 expression
did not merely reflect a more efficient egress of CXCR5 OT-II
cell under these conditions, because the same results were
obtained with FTY720-treated mice (data not shown). Taken
together, these results indicate that Tfh differentiation is selec-
tively augmented when a relatively high threshold in T cell activa-
tion signal strength is exceeded.
Tfh Cell Generation Is Selectively Impaired in the
Absence of Type I Interferon Signaling
Given the ability of IFN-a and -b to enhance the T cell stimulatory
capacity of APC, we assessed the role of IFN I in Tfh cell differ-
entiation. Following immunization with OVA and LPS, the
percentage and number of CXCR5+ OT-II cells were reduced in
MLNs and spleens of Ifnar1/ mice as compared to WT recipi-
ents (Figures 4A and 4C). Divided OT-II cells re-sorted from the
Ifnar1/ recipient’s spleens expressed less Bcl-6 and IL-21
mRNA than their counterparts sorted from WT mice
(Figure 4B). However, the Ifnar1/ recipients contained an over-
all reduced number of MLN and spleen OT-II cells (Figure 4C),
and although they had a similar percentage of MLN a4b7
+ OT-II
cells as WT recipients (Figure 4A), the number of a4b7
+ OT-II cells
was consequently also reduced in these mice (Figure 4C). OT-II
cells activated in Ifnar1/ mice had, however, proliferated only
slightly less than those activated in WT mice (Figure 4D), and
to determine if an increased egress accounted for their reduced
number in Ifnar1/ animals (Shiow et al., 2006), we repeated the
experiments but now treated the immunized recipients with
FTY720. When donor cells were trapped in lymphoid tissues,
a similar percentage and number of a4b7
+ OT-II cells were gener-
ated in the MLN of WT and Ifnar1/ mice (Figures 5A and 5B).
Likewise, the total number of OT-II cells was similar in the
spleens and MLNs of the two groups (Figure 5B). In marked
contrast, the percentage and number of CXCR5+ OT-II cells
were still greatly reduced in Ifnar1/ mice (Figures 5A and 5B).
Finally, we also observed a similar selective loss of CXCR5+
OT-II cells in FTY720-treated Ifnar1/ recipients when pI:C
was used as adjuvant (data not shown). These results collectively
demonstrate that IFN I stimulates the generation of LN resident
CXCR5+ Tfh cells but is not required for the generation of the
peripheral a4b7
+ effector Th cells.
Impaired Affinity Maturation and Follicular T Cell
Homing in Ifnar1/ Mice
Next, we compared serum titers of 4-Hydroxy-3-nitrophenylace-
tyl (NP)-specific Abs in WT and Ifnar1/ mice after i.p. immuni-
zation with NP-conjugated OVA and LPS. Two weeks after
a secondary challenge with NP-OVA, titers of specific IgM and
IgG were similar in both groups of mice (Figure 6A). The predom-
inant IgG subisotype produced was IgG1, and titers of specific
IgG1 were also comparable in WT and Ifnar1/ mice. In keeping
with previous reports (Le Bon et al., 2001; Proietti et al., 2002),
Immunity
IFN I-Dependent Generation of Tfh Cellsthe low titer of specific IgG2a produced was, however, reduced
in Ifnar1/ mice (Figure 6A). Because these results were
obtained by measuring serum anti-NP reactivity against densely
NP-conjugated BSA (NP23-BSA), which binds both low- and
high-affinity NP Abs, we next analyzed the same sera for high-
affinity NP-specific IgG in the ELISA by using a sparsely NP-
conjugated protein (NP2-PSA) (Roes and Rajewsky, 1993). By
this method, serum titers of high-affinity anti-NP IgG and IgG1
were found to be significantly (p < 0.001) reduced in Ifnar1/
mice compared with WT controls (Figure 6B).
Efficient generation of GCs requires CXCR5-dependent follic-
ular homing of primed CD4+ T cells. Thus, we compared the
Figure 4. Reduced Number of CXCR5+ Tfh
Cells in Ifnar1/ Mice
CFSE-labeled OT-II cells were transferred into WT
or Ifnar1/ mice that were immunized i.p. with
OVA and LPS.
(A) Representative flow cytometry results for
CXCR5 versus a4b7 expression 3 days after immu-
nization.
(B) Expression of IL-21 and Bcl-6 mRNA normal-
ized to b-actin in sorted spleen OT-II cells (mean ±
SD; n = 4).
(C) Number of total, CXCR5+, or a4b7
+ OT-II cells
in the MLN and spleen 3 and 6 days after immuni-
zation. Numbers from individual mice and mean
values from two pooled experiments are shown.
(D) Percentages (mean ± SD; n = 3) of total OT-II
cells as a function of cell-cycle number as judged
from CFSE dilution. One representative experi-
ment of two performed is shown. ***p < 0.001;
**p < 0.01; *p < 0.05.
numbers of OT-II cells that entered B cell
follicles in MLN of immunized WT and
Ifnar1/ recipients. In agreement with
the impaired generation of CXCR5+ OT-II
cells in Ifnar1/ mice, the density of
OT-II cells within the MLN B cell area
was significantly (p < 0.05) reduced
compared with WT mice (Figures 6C and
6D). These results show that the failure of Ifnar1/ mice to effi-
ciently support Tfh cell differentiation is accompanied by reduced
follicular T cell homing and impaired Ab affinity maturation.
IFNAR Signaling in CD11c+ DCs and Nonhematopoietic
Cells Underlies IFN I-Dependent Tfh Cell Differentiation
In Vivo
Robust IFN I production in response to LPS or pI:C depends on
IFNAR feedback signaling. The generation of Tfh cells could,
therefore, involve direct IFN I signaling in WT OT-II cells, and
reduced amounts of IFN-a and -b in Ifnar1/ recipients underlie
their impaired development in these mice. To address this, weFigure 5. Impaired Generation of CXCR5+
Tfh Cells in Ifnar1/ Mice
WT and Ifnar1/ mice were transferred with OT-II
cells and immunized as described in Figure 4.
Twenty hours later, the recipients were treated
with FTY720, and 3 days after immunization, the
total cells in MLN and spleen were counted and
the phenotype of donor cells was determined by
flow cytometry.
(A) Representative results for CXCR5 and a4b7
expression.
(B) Number of total, CXCR5+, or a4b7
+ OT-II cells in
the MLN and spleen. Numbers from individual
mice and mean values are shown. ***p < 0.001;
*p < 0.05.Immunity 31, 491–501, September 18, 2009 ª2009 Elsevier Inc. 495
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IFN I-Dependent Generation of Tfh CellsFigure 6. Impaired Affinity Maturation and Follicular T Cell Homing in Ifnar1/ Mice
(A and B) WT and Ifnar1/ mice were immunized i.p. with NP-OVA and LPS. Three weeks later, mice received NP-OVA i.p., and after 2 additional weeks, serum
was analyzed for NP-specific Abs by ELISA. Results obtained from individual mice and mean values are shown and are expressed as arbitrary units. (A) Serum
IgM, IgG, IgG1, and IgG2a reactivity against NP23-BSA. (B) Serum IgG and IgG1 reactivity against NP2-PSA.
(C) CD45.1+ OT-II cells were transferred into WT or Ifnar1/ recipients that were immunized i.p. with OVA and LPS. The density of OT-II cells within the MLN B cell
follicles was determined 3 days later by immunofluorescence analysis using mAbs to CD45.1 (green), B220 (blue), and TCRVb (red).
(D) Numbers (mean ± SD; n = 4) of OT-II cells/mm2 B cell follicle. ***p < 0.001; *p < 0.05.cotransferred IFNAR-deficient and -sufficient OT-II cells into
Ifnar1/ and WT mice, respectively. Three days after immuniza-
tion, the majority of OT-II cells in the MLN of WT recipients
expressed CXCR5, and this occurred to a similar degree on
the IFNAR-deficient and -sufficient donor cells (Figures 7A and
7B). The frequency of CXCR5+ OT-II cells was again strongly
reduced in the Ifnar1/ recipients, and this affected cotrans-
ferred IFNAR-deficient and -sufficient OT-II cells equally (Figures
7A and 7B). IFN I signaling in CD4+ T cells is, thus, dispensable
for Tfh cell development.
Next, we transferred WT OT-II cells into bone marrow (BM)
chimeras lacking the IFNAR on either hematopoietic or nonhe-
matopoietic cells. After immunization followed by FTY720 treat-
ment, the generation of CXCR5+a4b7
 OT-II cells was impaired in
the MLN of recipients lacking the IFNAR on hematopoietic
(Ifnar1// B6) or on nonhematopoietic (B6/ Ifnar1/) cells,
as compared with controls expressing the receptor on both cell
types (B6/ B6) (Figures 7C and 7D). However, this reduction
was most pronounced when hematopoietic cells lacked the
receptor (Figure 7D), indicating that IFN I signaling in APC plays
an important role. To dissect the contribution of individual
subsets of APC, we assessed Tfh development in conditional
(floxed) Ifnar1 mice (Ifnar1fl/fl) crossed with transgenic mouse
strains expressing the Cre recombinase under control of the
CD11c, CD19, or M lysozyme (LysM) promoters (Cervantes-Bar-
ragan et al., 2009; Prinz et al., 2008). The frequency and number
of CXCR5+a4b7
, but not a4b7
+CXCR5, OT-II cells were signif-
icantly (p < 0.01) reduced in the MLN of immunized recipients496 Immunity 31, 491–501, September 18, 2009 ª2009 Elsevier Inc.lacking the IFNAR selectively on CD11c+ DCs (Ifnar1fl/fl
CD11cCre), as compared with Ifnar1fl/fl controls (Figures 7E
and 7F). A reduced Tfh development in these mice was also
evident when the total number of CXCR5+ (rather than
CXCR5+a4b7
) OT-II cells was counted (reduced by 45 ± 15%
compared with Ifnar1fl/fl controls (mean value ± SD; n = 6;
p = 0.0170). We confirmed a selective, but incomplete, deletion
of the IFNAR on DCs in the Ifnar1fl/fl CD11cCre mice by flow
cytometry (Figure S3). The fact that we could detect IFNAR
expression on 13%–14% of CD11c+MHCII+ DCs in these
mice indicates that the importance of IFN I signaling in DCs
may even have been underestimated in these experiments. In
contrast to this, CXCR5+a4b7
 OT-II cells were not significantly
(p > 0.05) reduced in mice lacking the receptor selectively on
B cells (Ifnar1fl/fl CD19Cre) or on granulocytes and macrophages
(Ifnar1fl/fl LysMCre) (Figures 7E and 7F). Yet, we detected
a complete and selective deletion of the IFNAR on B cells in
Ifnar1fl/fl CD19Cre mice (Figure S3). The cell-specific IFNAR
deletion in the Ifnar1fl/fl LysMCre mice has recently been shown
to give substantial deletion on monocytes and macrophages and
a partial deletion on granulocytes (Prinz et al., 2008; Stockinger
et al., 2009). Collectively, these results demonstrate that IFNAR
signaling in DCs and in cells of nonhematopoietic origin underlies
the IFN I-dependent generation of CXCR5+ Tfh cells.
IFN I Enhances IL-6 Production from CD11c+ DCs
The ICOSL, in particular ICOSL expressed by B cells, CD28
ligands, and IL-6 are all required for efficient Tfh differentiation
Immunity
IFN I-Dependent Generation of Tfh CellsFigure 7. IFNAR Signaling in CD11c+ DCs
Stimulates Tfh Cell Differentiation and IL-6
Production
(A and B) CFSE-labeled Ifnar1/ (CD45.2+) and
WT (CD45.1+CD45.2+) OT-II cells were cotrans-
ferred into Ifnar1/ and WT mice (both CD45.2+),
respectively. Expression of CXCR5 on donor
cells in the MLN was determined by flow cytometry
3 days after immunization with OVA and LPS.
Total donor cell population was identified as
CFSE+TCRVa2+TCRVb5.1+ cells among PICD4+
B220 cells. (A) Representative flow cytometry
results. Numbers indicate percentages of cells
within quadrants. (B) Percentages (mean ± SD;
n = 4) of cotransferred WT and Ifnar1/ OT-II cells
expressing CXCR5 in WT and Ifnar1/ recipients.
(C–F) OT-II cells were transferred into indicated
cell-specific IFNAR-deficient or control mice.
Recipients were immunized with OVA and LPS,
and treated with FTY720 1 day later. The per-
centage and number of indicated OT-II cell subsets
in the MLN were determined 3 days after immuniza-
tion by flow cytometry analysis. (C and D) Results
obtained with IFNAR-sufficient control BM
chimeras (B6/ B6) and BM chimeras lacking the
IFNAR selectively on hematopoietic (Ifnar1/ /
B6) or nonhematopoietic (B6 / Ifnar1/) cells.
(C) Representative results. Numbers indicate
percentages of cells within quadrants. (D) Percent-
ages of CXCR5+a4b7
 OT-II cells. Individual mice
and mean values are shown (n = 5). (E and F)
Percentages CXCR5+a4b7
 OT-II cells (E) and
number CXCR5+a4b7
 and a4b7
+CXCR5 OT-II
cells (F) in indicated mouse strains. Pooled results
from two separate experiments are shown (n = 6,
except for Ifnar1fl/fl LysM Cre, where n = 3). (G)
IL-6 secretion from WT or Ifnar1/ CD11c+ DCs
stimulated with LPS, anti-CD40, or both, in the
absence or presence of neutralizing anti-IFNAR
or recombinant IFN-b. Supernatants were har-
vested after 20 hr, and IL-6 concentrations were
determined by ELISA. One representative experi-
ment (mean values of triplicate wells ± SD) of
four performed is shown. ***p < 0.001; **p < 0.01;
*p < 0.05.in vivo (Akiba et al., 2005; Haynes et al., 2007; Nurieva et al.,
2008; Walker et al., 1999). Wheras IFN I upregulates CD86 on
DCs and B cells (Montoya et al., 2002; Zhu et al., 2007b), it is
not required for expression of the ICOSL on these cells and,
instead, appears to inhibit TLR-mediated ICOSL induction
(Zhou et al., 2005). We confirmed that IFN I enhances expression
of CD86, but not ICOSL, on DCs and B cells in vivo (Figure S4),
suggesting that IFN I regulates Tfh cell development by mecha-
nisms distinct from ICOS and ICOSL interaction but possibly
involving an enhanced CD86 expression (Vogelzang et al.,
2008; Walker et al., 1999). Next, we measured IL-6 production
from CD11c+ DCs purified from WT and Ifnar1/ mice
(Figure 7G). LPS and anti-CD40 synergistically triggered abun-
dant IL-6 production by DCs from WT, but not from Ifnar1/,
mice, and this production was further enhanced by addition of
recombinant IFN-b, which also induced substantial production
from DCs stimulated with LPS in the absence of anti-CD40.
As expected, added IFN-b did not augment IL-6 secretion
from Ifnar1/ cells. A neutralizing Ab against the IFNAR reducedIIL-6 production from WT DCs to the degree obtained with
Ifnar1/ cells. These results collectively show that LPS-induced
IL-6 production by DCs is regulated by autocrine and paracrine
IFN I signaling.
DISCUSSION
In the current study, we have shown that separate subsets of
CXCR5+ Tfh cells and a4b7
+ gut tropic effector CD4+ T cells
are generated in the gut-draining MLN. This dichotomy in the
mucosa-associated Th cell response is, thus, analogous to the
findings of Campbell et al. (2001) that separable effector CD4+
T cell subsets specialized for B cell help or cutaneous inflamma-
tion develop in skin-draining LNs. We have focused our studies
on the MLNs because these LNs support the generation of a large
number of peripheral tissue tropic effector T cells that are easily
identified by their robust expression of the gut-homing molecule
a4b7. These a4b7
+ Th cells represent a subset of effector cells
clearly distinct from CXCR5-expressing Tfh cells, and we havemmunity 31, 491–501, September 18, 2009 ª2009 Elsevier Inc. 497
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with a rapid kinetics. In marked contrast to this, we provide
evidence for a highly efficient retention of the CXCR5+ Tfh cells
within the LN, which is consistent with their role as B cell-helping
effector T cells. Thus, these experiments reveal a fundamental
difference in the ability of recently generated effector Th cell
subsets to exit the lymphoid organs. During the preparation of
our revised manuscript, Fazilleau et al. (2009) reported similar
observations from studies on nonmucosal LNs. Except from
CXCR5+CD62L Tfh cell and CXCR5CD62L LN emigrant
effector Th cells, the authors identified a third population of
LN-resident and T cell-zone-localized CXCR5CD62L+ Th cells
with high expression of ICOS, T-bet, and in particular, Blimp-1
mRNA. We observed a MLN-resident subset that was enriched
for CD62L+ cells and also failed to acquire either CXCR5 or
a4b7 expression. We do not currently know if this subset is equiv-
alent to the CXCR5CD62L+ LN resident TH cells identified in the
nonmucosal LN or, alternatively, if the failure to downregulate
CD62L reflects a relatively poor T cell activation status of some
of these double-negative cells (Lanzavecchia and Sallusto,
2000).
The selective egress of a4b7
+ TH cells from the MLN indicates
that molecules differentially expressed by the a4b7
+ and CXCR5+
subsets regulate LN exit. When activated, T cells acquire tran-
sient expression of CD69, which downmodulates surface
expression of S1P1, leading to their transient sequestration
within the lymphoid tissues (Shiow et al., 2006). In agreement
with previous results (Fazilleau et al., 2007), we found that
CD69 was maintained selectively on a subset of CXCR5+ Tfh
cells. Downregulation of CD69 may, thus, underlie the rapid
and vigorous egress of a4b7
+ TH cells from the LN by conferring
regained sensitivity to S1P. The molecular mechanism
accounting for retention of LN-resident Th cells lacking detect-
able CD69 remains to be determined.
The cellular interactions underlying Tfh differentiation are
currently not fully elucidated but appear to involve sequential
priming on DCs and B cells because constitutive expression
of the OX40 ligand by DCs leads to increased T cell accumula-
tion within B cell follicles (Brocker et al., 1999) and TFH cell
differentiation is impaired in B cell-deficient mice or in mice
where the ICOS ligand is selectively absent on B cells (Haynes
et al., 2007; Nurieva et al., 2008). Our study demonstrates
that IFN I stimulates Tfh cell differentiation and that signaling
in DCs is important for this effect. This is consistent with the
ability of IFN-b to enhance Ab responses and induce isotype
switching when only DCs express the IFNAR (Le Bon et al.,
2001). Whereas IFN I clearly enhances T cell-dependent Ab
responses by direct signaling in T and B cells (Le Bon et al.,
2006), we show that Tfh differentiation is not affected when
these cells, or macrophages and granulocytes, are unable to
respond to IFN I. Instead, we show that IFNAR signaling in non-
hematopoietic cells also augments this differentiation process.
As IFN-a and -b expression in, for example, fibroblasts is rein-
forced by an early IFN-b-dependent induction of interferon
regulatory factor (IRF)-7 (Erlandsson et al., 1998; Sato et al.,
2000), impaired Tfh cell generation in mice lacking IFNAR
selectively on nonhematopoietic cells could reflect DCs sensing
reduced amounts of IFN-a and -b in these mice. Currently,
however, we cannot exclude the possibility that LN stromal498 Immunity 31, 491–501, September 18, 2009 ª2009 Elsevier Inc.cells interact physically or via soluble mediators with CD4+
T cells and that such molecular interactions occur downstream
of IFN I signaling.
It is clear from the literature that IFN I strengthens the T cell
stimulatory capacity of DCs by mechanisms involving increased
expression of MHC and costimulatory molecules, including
CD86, but not the ICOSL (Le Bon and Tough, 2002; Zhou
et al., 2005). A strong TCR signal strength (Fazilleau et al.,
2009) and robust costimulation (Vogelzang et al., 2008; Walker
et al., 1999) appear to be essential for Tfh cell differentiation.
This is not the least reflected by the preferential selection of
high-affinity clones into the Tfh cell compartment (Fazilleau
et al., 2007) and by our results herein, showing that CXCR5 is
selectively expressed by the most divided effector Th cells and
that coinjection of a CD40 mAb and pI:C leads to an enhanced
generation of Tfh cells, but not a4b7
+ peripheral effectors. Finally,
IL-6 and its direct signaling in T cells appear to be important as
IL-6 deficiency, or T cell-specific deletion of the IL-6-receptor-
associated signaling molecule STAT3, leads to reduced Tfh
differentiation (Nurieva et al., 2008). We show here that IL-6
production from LPS-exposed DCs is regulated by autocrine
and paracrine IFN I signaling, and previous work has identified
a critical role for autocrine IFN I signaling in adenovirus-induced
IL-6 production (Fejer et al., 2008; Zhu et al., 2007a). As the IFN
I-dependent IL-6 production from DCs was further augmented
by CD40 engagement on these cells, it seems possible that
CD40L-expressing TH cells elicit abundant IL-6 secretion from
DCs under IFN I-permissive conditions.
As we could not detect a reduced development of emigrant
a4b7
+ TH cells in the absence of IFN I signaling, IFNAR deficiency
appears to selectively affect the LN resident Tfh cells while
leaving the peripheral Th cell compartment relatively intact.
However, published results have identified a deviation from
a Th1 to a Th17 orientated response in IFNAR-deficient mice
(Guo et al., 2008; Shinohara et al., 2008), indicating that the
nature of the peripheral Th cell response under some conditions
is modified by IFN I. The generation of a4b7
+ T cells is regulated
by a functionally specialized subset of CD103+ DCs derived from
the gut mucosa and the vitamin A metabolite retinoic acid (Iwata
et al., 2004; Johansson-Lindbom et al., 2005). Because CXCR5
and a4b7 are expressed in a mutually exclusive manner on Th
cells activated in the MLN and IFNAR deficiency does not affect
the generation of the a4b7
+ subset, it seems possible that distinct
subsets of DCs regulate the generation of these two effector Th
cell subsets. This, however, remains to be determined by in vitro
experiments with purified subsets of APCs.
Our results further reveal that the failure of Ifnar1/ mice to
efficiently support Tfh cell differentiation and accumulation
within B cell follicles is linked with an impaired Ab affinity matu-
ration. This is in agreement with previous results, showing that
IFN I promotes GC formation and is critical for production of
neutralizing Abs following adenoviral infection (Zhu et al.,
2007b). We found that Ifnar1/ mice however displayed normal
serum titers of low affinity NP-specific IgG. This could be
explained by the relatively high dose of densely NP-conjugated
OVA that we used for immunization; an immunization regime
likely to have provoked a strong T cell dependent extra-follicular
Ab response as abundant epitopes steer B cells toward extra-
follicular plasma cell differentiation (Paus et al., 2006).
Immunity
IFN I-Dependent Generation of Tfh CellsAn increased number of Tfh cells has been observed in
different Ab-mediated autoimmune diseases and in particular
in murine models for SLE, such as sanroque mice (Vinuesa
et al., 2005) or the bicongenic B6.Sle1yaa mice (Subramanian
et al., 2006). In addition, Tfh cells were recently shown to be
required for the systemic pathology that develops in sanroque
mice (Linterman et al., 2009). Although we are not aware of any
studies on IFN I in the context of lupus-associated Tfh cell differ-
entiation, this family of cytokines is an integral part of SLE
pathology (Banchereau and Pascual, 2006). Indeed, SLE
patients have increased serum titers of IFN-a that correlate posi-
tively with serum anti-DNA reactivity and disease severity
(Bengtsson et al., 2000), and IFN I treatment of nonautoimmune
disorders frequently gives rise to production of autoantibodies
and occasionally humoral autoimmune symptoms (Belardelli
and Gresser, 1996). Studies in different lupus-prone mouse
strains have also revealed a critical role for IFN I in murine
lupus-like pathology (Braun et al., 2003; Mathian et al., 2005;
Santiago-Raber et al., 2003). IFN I-dependent Tfh cell generation
in humoral autoimmunity clearly merits further investigation.
In summary, we have shown that the mucosal peripheral tissue
tropic and lymph-node-resident effector CD4+ T cell compart-
ments develop independently and that IFN I acts as an adjuvant
on DCs to selectively stimulate the generation of the lymph-
node-resident CXCR5+ Tfh cells. These results are highly rele-
vant to the development of vaccines and may prove useful for
clarification of mechanisms underlying Ab mediated autoim-
mune disease.
EXPERIMENTAL PROCEDURES
Mice
Ifnar1/ mice on a C57Bl/6 background (provided by J. Demengeot [Instituto
Gulbenkian de Cieˆncia, Oeiras, Portugal]), C57Bl/6 (Taconic), C57Bl/6-
CD45.1, and OT-II mice were bred and maintained at the Biomedical Center
animal facility (Lund University, Lund, Sweden). CD45.1+CD45.2+ OT-II mice
were obtained from OT-II 3 C57Bl/6-CD45.1 mating. Ifnar1/ OT-II mice
were obtained by crossing OT-II3 Ifnar1/ litters and screening the offspring
by flow cytometry using Abs against TCRVa2, TCRVb5.1, and the IFN I
receptor (MAR1-5A3, Leinco Technologies, Inc.). Ifnar1fl/fl CD11cCre, Ifnar1fl/fl
CD19Cre, Ifnar1fl/fl LysMCre, and Ifnar1fl/fl mice have been described else-
where (Cervantes-Barragan et al., 2009; Prinz et al., 2008). Animal experiments
were performed in accordance with guidelines from the Lund and Malmo¨
Animal Ethics Committee.
Adoptive Transfers
Spleen and LN cells from OT-II mice were labeled with 5 mM carboxyfluores-
cein diacetate succinimidyl ester (CFSE), and total cells corresponding to
106 CD4+TCRVa2+ cells were transferred into CD45 congenic recipients. In
experiments with Ifnar1/ recipients, CD4+ donor T cells were first enriched
by negative MACS selection (Miltenyi Biotech). Recipients were immunized
i.p. with 500 mg OVA in the absence or presence of 50 mg LPS, 100 mg pI:C
(all from Sigma-Aldrich), or 50 mg anti-CD40 mAb (IC11, Biolegend). In some
experiments, mice received FTY720 (1 mg/kg body weight; Cayman) in saline
i.p. 18–24 h later. Mice were euthanized 2–6 days later, and organs were
collected after perfusion of the liver with 10 ml PBS. Isolation of leukocytes
from indicated tissues was performed as previously described (Stenstad
et al., 2006).
Bone Marrow Chimeras
The recipients were irradiated (1000 rad) before 4 3 106 bone marrow cells,
were prepared from femurs and tibias of donor mice, and were transferred
by i.v. injection. After 7 weeks, the mice were used in adoptive transfer exper-Iiments as described above. Chimerism was confirmed by flow cytometry using
biotin anti-IFNAR mAb and PE SA (BD PharMingen).
Flow Cytometry Analysis and Cell Sorting
Cells were incubated with anti-CXCR5 (2G8, provided by O. Pabst, Hanover
Medical School, Hanover) followed by APC donkey F(ab’)2 anti-rat IgG (eBio-
science). After blocking remaining anti-rat reactivity with 10% rat serum, cells
were incubated with propidium iodide (PI) and fluorochrome-conjugated rat or
mouse mAbs to the following markers: CD4 (RM4-5), B220 (RA3-6B2), CD62L
(MEL-14) (eBioscience), a4b7 (DATK32, BD PharMingen), and either CD45.2
(104, eBioscience) or CD45.1 (A20, BioLegend). In experiments described in
Figure 7, the total population of cotransferred WT and Ifnar1/ OT-II cells
was identified by TCRVa2 mAb (B20.1, eBioscience) and biotin TCRVb5.1, fol-
lowed by QD605 SA. Acquisition of data and sorting of indicated OT-II cell
subsets were done on a FACSAria (BD Biosciences). Sorting and analysis of
donor cells were performed after gating on PI (viable) CD4+B220 cells
also staining positive for the donor-specific CD45 isoform. Data analysis
was done using the FlowJo software (Tree Star, Inc.).
Immunofluorescence Microscopy
Cryostat sections (9 mm) were fixed in 4% PFA, quenched with 3% H2O2 in
PBS, and blocked with mouse and rat serum (5% of each in PBS) and a
SA-biotin blocking kit (Vector Laboratories). Sections were incubated with
biotin anti-CD45.1 (A20) and anti-TCRb (H57-597, eBioscience), followed by
horseradish peroxidase (HRP) SA (Invitrogen), Cy3 goat anti-hamster IgG
(polyclonal, Jackson ImmunoReserach), and Alexa Fluor 647 anti-B220
(RA3-6B2, Biolegend). HRP was revealed using a tyramide Alexa Fluor 488
Amplification Kit (Invitrogen). Analysis was done with an Axiovert 200 micro-
scope (Carl Zeiss, Inc.) and Volocity software (Improvision).
Quantitative Real-Time PCR
Spleen and MLN from immunized OT-II cell recipient mice (C57Bl/6 or Ifnar1/)
were first enriched for CD4+ T cells by negative selection using anti-CD19-
conjugated MACS beads and LS columns (Miltenyi Biotech). Total divided
OT-II cell or indicated subsets were sorted on a FACSAria as described above.
RNA was prepared with a RNeasy Micro Kit (QIAGEN) and converted into line-
arly amplified cDNA by WT-Ovation Pico RNA Amplification System (NuGEN
Technologies, Inc). The cDNA was purified by QIAquick PCR Purification Kit
(QIAGEN). QRT-PCR was performed using 20 ng cDNA template, SYBR Green
ER qPCR SuperMix (Invitrogen), and 0.5 mM of forward and reverse primers
in a final volume of 20 ml. Reactions were run and recorded on an iCycler
(Bio-Rad). Primer sequences are described in Supplemental Data.
NP-Specific ELISA
Sera from C57Bl/6 and Ifnar1/ mice immunized i.p. 5 weeks previously with
500 mg NP19-OVA (Biosearch Technologies, Inc.) and 50 mg LPS, and given an
i.p. boost with 200 mg NP19-OVA 2 weeks before collection of the sera, were
analyzed for NP-specific Abs. To this end, 96-well plates coated with NP23-
BSA (broad-affinity range) or NP2-Porcrine serum albumin (PSA) (high-affinity)
(both from Biosearch Technologies, Inc.) were used. Plates were blocked with
1% BSA in PBS and incubated with serial dilutions of the sera and a reference
immune serum serving as an interplate standard. Serum Abs bound to NP
conjugates were detected with biotin anti-mouse IgG (polyclonal g-specific,
Southern Biotech) and biotinylated isotype-specific mAbs from Biolegend:
IgM (RMM-1), IgG1 (RMG1-1), and IgG2a/c (RMG2a-62). Plates were devel-
oped with HRP-SA (Biolegend) followed by 3,30, 5,50- tetramethyl-benzidine
dihydro-chloride hydrate (TMB) substrate solution (Sigma-Aldrich). The reac-
tion was terminated with 2 M H2SO4, and plates were read at 450 nm on a
microplate ELISA reader (Molecular Devices). Serum anti-NP reactivity is given
in arbitrary units/ml and is calculated using the reference immune serum as
standard. The titer of this standard was set to the inverse dilution factor
required to reach 50% of the optical maximum value.
IL-6 Production from DCs
DCs were purified from collagenase-IV-digested spleens with CD11c MACS
beads as previously described. Preparations routinely contained 90%–95%
CD11c+MHCII+ cells as assessed by flow cytometry. DCs were cultured in
complete RPMI 1640 media at 5 3 105 cells/ml in the absence or presencemmunity 31, 491–501, September 18, 2009 ª2009 Elsevier Inc. 499
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nant IFN-b (R&D systems; 400 U/ml), and/or anti-IFNAR (MAR1-5A3; 10 mg/ml)
as indicated. Supernatants were collected after 20 hr, and the concentration of
IL-6 was determined by sandwich ELISA using capture rat anti-IL-6 (MP5-
20F3) and detection biotin rat anti-IL-6 (MP5-32C11) mAbs (Biolegend).
Cytokine ELISA
OT-II cell recipient mice (C57Bl/6) were immunized i.p. with 500 mg OVA and
50 mg LPS, and 3 days after, indicated OT-II cell subsets were sorted on a
FACSAria as described above. Cells were restimulated in vitro with plate-
bound anti-CD3 (10 mg/ml) and soluble anti-CD28 (1 mg/ml) for 24 hr. Culture
supernatants were analyzed for IL-4, IL-10, IL-17 and IFN-g by sandwich
ELISA with the following rat capture and detection mAbs: anti-IL-4 (11B11),
biotin anti-IL-4 (BVD6-24G2), anti-IL-10 (JES5-2A5) (all produced in the lab
from hybridomas), biotin anti-IL-10 (JES5-16E3), anti-IL17A (TC11-18H10.1),
biotin anti-IL17A (TC11-8H4) (all from Biolegend), anti-IFN-g (R4-6A2), and
biotin anti-IFN-g (XMG1.2) (both from BD PharMingen).
Statistical Analysis
Statistical analyses were performed using unpaired or paired two-tailed
Student’s t test.
SUPPLEMENTAL DATA
Supplemental Data include four figures and can be found with this article online
at http://www.cell.com/immunity/supplemental/S1074-7613(09)00365-3.
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